TAM
TEVA icon

Todd Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Todd Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128M Buy
3,790,007
+18,335
+0.5% +$611K 2.28% 2
2026
Q1 		$114M Sell
3,771,672
-5,465
-0.1% -$176K 2.22% 1
2025
Q4 		$118M Sell
3,777,137
-259,460
-6% -$6.39M 2.3% 1
2025
Q3 		$81.5M Buy
4,036,597
+112,477
+3% +$1.98M 1.65% 1
2025
Q2 		$65.8M Buy
3,924,120
+991,378
+34% +$16M 1.42% 12
2025
Q1 		$45.1M Buy
2,932,742
+290,154
+11% +$5.18M 1.06% 29
2024
Q4 		$58.2M Buy
+2,642,588
New +$48.1M 1.4% 14
2016
Q4 		– Sell
-213,622
Closed -$9.83M – 225
2016
Q3 		$9.83M Sell
213,622
-139,789
-40% -$7.29M 0.3% 136
2016
Q2 		$17.8M Buy
353,411
+559
+0.2% +$29.8K 0.57% 69
2016
Q1 		$18.9M Buy
352,852
+189,361
+116% +$11.1M 0.56% 70
2015
Q4 		$10.7M Buy
+163,491
New +$10.1M 0.33% 114
2015
Q2 		– Sell
-52,110
Closed -$3.25M – 241
2015
Q1 		$3.25M Buy
+52,110
New +$3.03M 0.09% 157

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Todd Asset Management's TEVA Position: Q2 2026 in Review

Todd Asset Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 0.49% in Q2 2026, buying an estimated $611K and bringing the position to 3,790,007 shares worth $128M. The position accounts for 2.28% of the portfolio, ranked #2.

Todd Asset Management first reported a position in TEVA in Q1 2015 and has held it in 12 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Todd Asset Management held 3,790,007 shares of Teva Pharmaceutical Industries Limited worth $128M as of Q2 2026.
  • Todd Asset Management bought 18,335 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $611K.
  • Teva Pharmaceutical Industries Limited made up 2.28% of Todd Asset Management's portfolio in Q2 2026, its #2 holding.
  • Todd Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2015 and has held it in 12 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Todd Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.